Renalytix
$1.41
23
+$0.03+2.17% Today
Statistics
Day High
1.35
Day Low
1.35
52W High
202.5
52W Low
1.31
Volume
2,192
Avg. Volume
2,516
Mkt Cap
467M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
26MarExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-1,986.46%Profit Margin
Unprofitable4.58MRevenue
-90.94MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RNLXY. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Quest Diagnostics
DGX
Mkt Cap22.03B
Labcorp
LH
Mkt Cap22.69B
Exact Sciences
EXAS
Mkt Cap20.03B
Guardant Health
GH
Mkt Cap12.31B
Fulgent Genetics
FLGT
Mkt Cap525.3M
QuidelOrtho
QDEL
Mkt Cap1.17B
Neogenomics
NEO
Mkt Cap1.04B
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
About
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. The company's products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. It has a license agreement with Mount Sinai Health System to develop and commercialize its products in connection with the application of artificial intelligence for the diagnosis of kidney disease. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. The company was incorporated in 2018 and is based in London, the United Kingdom.
Show more...
CEO
Mr. James R. McCullough M.B.A.
Employees
46
Country
DE
ISIN
US75973T2006
Listings
0 Comments
Share your thoughts
FAQ
What is Renalytix stock price today?▼
The current price of RNLXY is $1.41 USD — it has increased by +2.17% in the past 24 hours. Watch Renalytix stock price performance more closely on the chart.
What is Renalytix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Renalytix stocks are traded under the ticker RNLXY.
Is Renalytix stock price growing?▼
RNLXY stock has fallen by -9.33% compared to the previous week, the month change is a -41.88% fall, over the last year Renalytix has showed a -72.8% decrease.
What is Renalytix market cap?▼
Today Renalytix has the market capitalization of 467M
When is the next Renalytix earnings date?▼
Renalytix is going to release the next earnings report on November 03, 2026.
What is Renalytix revenue for the last year?▼
Renalytix revenue for the last year amounts to 4.58M USD.
What is Renalytix net income for the last year?▼
RNLXY net income for the last year is -90.94M USD.
How many employees does Renalytix have?▼
As of April 08, 2026, the company has 46 employees.
In which sector is Renalytix located?▼
Renalytix operates in the Health Care sector.
When did Renalytix complete a stock split?▼
The last stock split for Renalytix was on December 15, 2025 with a ratio of 0.04:1.
Where is Renalytix headquartered?▼
Renalytix is headquartered in London, DE.